April 9 (Reuters) -
* FDA'S WOODCOCK-WILL REVIEW PFIZER'S REQUEST TO AMEND EUA TO EXPAND AGE RANGE FOR ITS COVID19 VACCINE TO INCLUDE INDIVIDUALS 12-15 YEARS OF AGE -TWEET
Source text: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
* FDA'S WOODCOCK-WILL REVIEW PFIZER'S REQUEST TO AMEND EUA TO EXPAND AGE RANGE FOR ITS COVID19 VACCINE TO INCLUDE INDIVIDUALS 12-15 YEARS OF AGE -TWEET
Source text: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)